Related Experiment Video
Updated: Oct 19, 2025

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
Infantile hypercalcaemia type 1: a vitamin D-mediated, under-recognised cause of hypercalcaemia
Ryizan Nizar1, Nathan W P Cantley2, Jonathan C Y Tang3
1Department of Diabetes and Endocrinology, Southmead Hospital, North Bristol NHS Trust, Bristol, UK.
Insights
Infantile hypercalcaemia type 1 (IIH) is a genetic disorder caused by CYP24A1 gene mutations, leading to high calcium levels and kidney problems. Early diagnosis and management, including vitamin D and calcium restriction, are crucial for preventing severe complications.
Area of Science:
- Endocrinology
- Genetics
- Metabolic Disorders
Background:
- Infantile hypercalcaemia type 1 (IIH) is an autosomal recessive disorder.
- It is characterized by homozygous mutations in the CYP24A1 gene, affecting vitamin D metabolism.
- IIH can lead to serious complications like nephrocalcinosis, nephrolithiasis, and metabolic bone disease.
Purpose of the Study:
- To present a case of a 33-year-old gentleman with a 21-year history of unexplained hypercalcaemia.
- To highlight the diagnostic process and genetic confirmation of Infantile hypercalcaemia type 1 (IIH).
- To discuss the management strategies for IIH.
Main Methods:
- Clinical presentation and family history assessment.
- Biochemical investigations of vitamin D metabolism.
- Molecular genetic analysis to identify CYP24A1 gene variants.
Main Results:
- A homozygous, likely pathogenic variant in CYP24A1 was identified, confirming the diagnosis of IIH.
- The patient presented with a 21-year history of hypercalcaemia, nephrolithiasis, nephrocalcinosis, and myocarditis.
- Biochemical hallmarks included persistent hypercalcaemia, normal/raised 25-(OH)-vitamin D, and elevated 1,25-(OH)2-vitamin D.
Conclusions:
- IIH should be suspected in individuals with unexplained hypercalcaemia, especially with childhood onset and family history.
- Management involves limiting vitamin D intake and restricting dietary calcium.
- Prompt diagnosis and management are essential to prevent severe renal and bone complications.
Summary:
A 33-year-old gentleman of Egyptian heritage presented with a 21 years history of unexplained and recurrent hypercalcaemia, nephrolithiasis, nephrocalcinosis, and myocarditis. A similar history was also found in two first-degree relatives. Further investigation into the vitamin D metabolism pathway identified the biochemical hallmarks of infantile hypercalcaemia type 1 (IIH). A homozygous, likely pathogenic, variant in CYP24A1 was found on molecular genetic analysis confirming the diagnosis. Management now focuses on removing excess vitamin D from the metabolic pathway as well as reducing calcium intake to achieve serum-adjusted calcium to the middle of the reference range. If undiagnosed, IIH can cause serious renal complications and metabolic bone disease.
Learning Points:
Infantile hypercalcaemia type 1 (IIH) is an autosomal recessive disorder characterised by homozygous mutations in the CYP24A1 gene that encodes the 24-hydroxylase enzyme used to convert active vitamin D metabolites such as 1,25-(OH)2-vitamin D into their inactive form. IIH should be questioned in individuals presenting with a history of unexplained hypercalcaemia, especially if presenting from childhood and/or where there is an accompanying family history of the same in first and/or second degree relatives, causing complications such as nephrocalcinosis, pericarditis, and calcium-based nephrolithiasis. Associated biochemistry of IIH is persistent mild to moderate hypercalcaemia, normal or raised 25-(OH)-vitamin D and elevated 1,25-(OH)2-vitamin D. An elevated ratio of 25-(OH)-vitamin D to 24,25-(OH)2-vitamin D can be a useful marker of defects in the 24-hydroxylase enzyme, whose measurement can be facilitated through the supra-regional assay service. Management should focus on limiting the amount of vitamin D introduced into the body either via sunlight exposure or supplementation in addition to calcium dietary restriction to try and maintain appropriate calcium homeostasis.
More Related Videos
07:13Two Techniques to Create Hypoparathyroid Mice: Parathyroidectomy Using GFP Glands and Diphtheria-Toxin-Mediated Parathyroid Ablation
Published on: March 14, 2017
08:43Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Related Concept Videos
Role of Skin in Vitamin D Synthesis
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
Skeleton and Calcium Homeostasis
Synthesis and Functions of Calcitonin
The exact mechanisms by which calcitonin operates in calcium homeostasis remain elusive, but its significance is evident in several vital...
Inborn Errors of Metabolism
Introduction to Electrolytes
Role of Sodium
One...
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...